tirzepatide discontinuation Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 Flow of Participants in the

Some users find that injecting in the morning gives GI side effects time to settle before bed

Tirzepatide (Mounjaro, Zepbound) Tirzepatide activates both GLP-1 and GIP receptors, providing stronger weight loss effects than semaglutide in head-to-head trials

Diabetic vascular complications often coexist with autonomic neuropathy, disrupting local vascular regulation in the testes

A specific gut microbiota dysbiosis of type 2 diabetic mice induces GLP-1 resistance through an enteric NO-dependent and gut-brain axis mechanism

FSSAI certified, NABL tested

NICE guidance recommends fracture risk assessment using FRAX or QFracture tools, with DXA scanning arranged when results would influence management decisions